ProFound AI Risk

Diagnostics and imaging · by iCAD, Inc.

Image-based short-term risk evaluation solution providing a 1 or 2 year probability score for developing breast cancer; CE Marked and Health Canada Licensed, not FDA Cleared, available in US for investigational use only.

What it does

Image-based short-term risk evaluation solution providing a 1 or 2 year probability score for developing breast cancer; CE Marked and Health Canada Licensed, not FDA Cleared, available in US for investigational use only.

  • AI-powered mammography analysis for early breast cancer detection
  • AI-based breast density assessment
  • Image-based short-term breast cancer risk evaluation
  • Workflow optimization for mammography reading
Category
Diagnostics and imaging
Built for
Healthcare and life sciences
Users
Radiologists, Healthcare Providers, Breast Imaging Centers, Patients
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

iCAD, Inc. doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

iCAD, Inc. hasn't published certifications or security practices for ProFound AI Risk that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use ProFound AI Risk at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim ProFound AI Risk